tiprankstipranks
Advertisement
Advertisement

High Tide, NuLeaf Join New U.S. Council to Shape Cannabinoid Care Policy

Story Highlights
  • High Tide and NuLeaf Naturals joined the National Compassionate Care Council as founding members to help shape U.S. medical cannabis policy.
  • The move positions High Tide to influence evolving federal standards and expand patient access, benefiting its U.S. hemp-derived CBD operations.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
High Tide, NuLeaf Join New U.S. Council to Shape Cannabinoid Care Policy

Claim 55% Off TipRanks

High Tide ( (TSE:HITI) ) has shared an update.

High Tide and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals have joined the newly formed National Compassionate Care Council as founding members, aligning with other healthcare-focused cannabis organizations dedicated to improving patient access to cannabinoid therapies. The move positions High Tide to help shape emerging U.S. medical cannabis standards and evidence-based policy, particularly as federal initiatives around cannabis rescheduling and potential Medicare reimbursement for hemp-derived products gain momentum, with potential operational and market implications for its American CBD businesses.

By contributing its experience from brands such as NuLeaf Naturals and FAB CBD, High Tide aims to support efforts to modernize healthcare standards, prioritize product quality and patient outcomes, and expand access to safe cannabinoid treatments nationwide. Participation in the council underscores the company’s strategy to deepen its influence in U.S. healthcare policy for cannabinoids, which could strengthen its industry positioning and benefit patients, regulators and its own hemp-derived CBD subsidiaries as regulatory frameworks evolve.

The most recent analyst rating on (TSE:HITI) stock is a Sell with a C$3.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.

Spark’s Take on TSE:HITI Stock

According to Spark, TipRanks’ AI Analyst, TSE:HITI is a Neutral.

The score is driven primarily by weakened financial performance (2025 loss resurgence and materially higher leverage) and bearish technicals (below key moving averages with negative MACD and very weak RSI/Stochastic). Positive operating/free cash flow provides some support, but valuation is constrained by ongoing losses and no stated dividend yield.

To see Spark’s full report on TSE:HITI stock, click here.

More about High Tide

High Tide Inc. is a community-grown, retail-forward cannabis enterprise with diversified operations spanning recreational retail, medical distribution and e-commerce for accessories and hemp-derived CBD products. Its Canna Cabana chain is Canada’s largest cannabis retailer with 219 locations and about 12% domestic market share, while German unit Remexian Pharma imports and wholesales medical cannabis from 19 countries. NuLeaf Naturals, founded in 2014 in Denver, is a leading U.S. cannabinoid company producing high-potency, cGMP-manufactured formulations sold online and through select brick-and-mortar outlets across the country.

Average Trading Volume: 96,786

Technical Sentiment Signal: Sell

Current Market Cap: C$298.7M

Learn more about HITI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1